Steris (STE) Liabilities and Shareholders Equity (2018 - 2026)
Steris (STE) recorded quarterly Liabilities and Shareholders Equity of $10.7 billion in Q1 2026, up 1.38% quarter-over-quarter from $10.6 billion in Q4 2025, and up 5.82% on a YoY basis from $10.1 billion in Q1 2025.
Steris (STE) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Steris' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $10.7 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 5.82% year-over-year to $10.7 billion; the TTM figure through Mar 2026 stood at $42.1 billion (up 4.04% YoY), while the FY2026 annual figure was $10.7 billion, up 5.82% from the prior year.
- Liabilities and Shareholders Equity was $10.7 billion for Q1 2026 at Steris, up from $10.6 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $11.4 billion in Q4 2023 to a low of $10.0 billion in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $10.7 billion across 5 years, with a median of $10.7 billion in 2026.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 73.76% in 2022, then slipped 12.48% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $10.8 billion in 2022, then climbed by 5.88% to $11.4 billion in 2023, then retreated by 12.48% to $10.0 billion in 2024, then grew by 5.83% to $10.6 billion in 2025, then climbed by 1.38% to $10.7 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $10.7 billion (Q1 2026), $10.6 billion (Q4 2025), and $10.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.74 Bn |
| Dec 31, 2025 | 10.59 Bn |
| Sep 30, 2025 | 10.41 Bn |
| Jun 30, 2025 | 10.41 Bn |
| Mar 31, 2025 | 10.15 Bn |
| Dec 31, 2024 | 10.01 Bn |
| Sep 30, 2024 | 10.24 Bn |
| Jun 30, 2024 | 10.11 Bn |
| Mar 31, 2024 | 11.06 Bn |
| Dec 31, 2023 | 11.44 Bn |
| Sep 30, 2023 | 11.28 Bn |
| Jun 30, 2023 | 10.78 Bn |
| Mar 31, 2023 | 10.82 Bn |
| Dec 31, 2022 | 10.80 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 11.19 Bn |
| Mar 31, 2022 | 11.42 Bn |
| Dec 31, 2021 | 11.69 Bn |
| Sep 30, 2021 | 11.75 Bn |
| Jun 30, 2021 | 12.10 Bn |